nanotech investing Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
nanotech investing Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy
nanotech investing Satellos to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
nanotech investing Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters' Option to Purchase Additional Shares
nanotech investing Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States
nanotech investing Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq
nanotech investing Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs
Juggernaut Exploration Announces Bought Deal Private Placement Structured Flow-Through Financing for Gross Proceeds of C$10M
Juggernaut Exploration Announces Bought Deal Private Placement Structured Flow-Through Financing for Gross Proceeds of C$10M
